Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21
Prabhanshu Tripathi, Ja‐Hyun Koo, Xuejun Chen, Lais Da Silva Pereira, Marlon Dillon, Baoshan Zhang, Mariah Lofgren, Katelyn T. Nguyen, I‐Ting Teng, Brian G. Bonilla, Sarah Kerscher, Wing‐Pui Kong, Amy R. Henry, Tyler Stephens, Yaroslav Tsybovsky, , Tongqing Zhou
This paper develops a nanoparticle-based junctional vaccine targeting PfCSP and compares its efficacy to the R21 vaccine in reducing malaria liver burden in mice.
npj Vaccines · Apr 27, 2026Peer-reviewedImmunology